Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Sibutramine metabolites increase glucose transport by cultured rat muscle cells

International Journal of Obesity volume 25, pages 478–485 (2001)Cite this article

Abstract

BACKGROUND: The anti-obesity agent sibutramine, a serotonin and noradrenaline reuptake inhibitor (SNRI), has been shown to reduce insulin resistance and improve glycaemic control in obese-diabetic ob/ob mice and overweight type 2 diabetic patients.

OBJECTIVE: To investigate whether sibutramine or its metabolites act directly on muscle cells to improve glucose uptake and insulin action.

DESIGN: Uptake of the non-metabolized glucose analogue 2-deoxyglucose was measured in cultured L6 rat muscle cells after incubation with sibutramine, its two pharmacologically active metabolites and related agents.

RESULTS: Sibutramine itself (10−8–10−6M) did not significantly affect 2-deoxyglucose uptake during incubations up to 72 h. The primary amine metabolite M2 (10−7 and 10−6M) increased basal and insulin-stimulated 2-deoxyglucose uptake (by 12% and 34%) after 24 h incubation. These effects of M2 were lost by 72 h incubation. However, the secondary amine metabolite M1 (10−6 M) increased basal and insulin-stimulated 2-deoxyglucose uptake (by 50%) after 72 h incubation, although M1 was ineffective after 24 h. M2 stimulated 2-deoxyglucose uptake in the presence of LY-294,002 (an inhibitor of phosphatidylinositol 3-kinase) but the effect of M2 was inhibited by cytochalasin B, which acutely blocks glucose transporters. Incubations with serotoninergic, noradrenergic and dopaminergic agents, or agents known to stimulate release or inhibit reuptake of these substances in nervous tissues indicated that the sibutramine metabolites were not affecting 2-deoxyglucose uptake via mechanisms associated with their SNRI properties.

CONCLUSIONS: Sibutramine metabolites can improve insulin-sensitive 2-deoxyglucose uptake by cultured muscle cells independently of SNRI effects.

International Journal of Obesity (2001) 25, 478–485

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Buckett WR, Thomas PC, Luscombe GP . The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation Prog Neuropsychopharmacol Biol Psychiat 1988 12: 575–584.

    Article  CAS  Google Scholar 

  2. Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR . The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride Neuropharmacology 1989 28: 129–134.

    Article  CAS  Google Scholar 

  3. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ . Thermogenic effects of sibutramine and its metabolites Br J Pharmac 1999 126: 1487–1495.

    Article  CAS  Google Scholar 

  4. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ . Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat Br J Pharmac 1997 121: 1613–1618.

    Article  CAS  Google Scholar 

  5. Day C, Bailey CJ . Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice Int J Obes Relat Metab Disord 1998 22: 619–623.

    Article  CAS  Google Scholar 

  6. McNeely W, Gor KL . Sibutramine: a review of its contribution to the management of obesity Drugs 1998 56: 1093–1124.

    Article  CAS  Google Scholar 

  7. Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML . Sibutramine in weight control: a dose-ranging efficacy study Clin Pharmac Ther 1991 50: 330–337.

    Article  CAS  Google Scholar 

  8. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E . Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine Am J Med 1999 106: 179–184.

    Article  CAS  Google Scholar 

  9. Vargas R, McMahan FG, Jain AK . Effects of sibutramine versus placebo in NIDDM Clin Pharmac Ther 1994 53: 188.

    Google Scholar 

  10. Griffiths J, Brynes AE, Frost G, Bloom SR, Finer N, Jones SP, Romanec FM . Sibutramine in the treatment of overweight non-insulin dependent diabetics Int J Obes Relat Metab Disord 1995 19 (Suppl 2): 41.

    Google Scholar 

  11. Yaffe D . Retention of differentiation potentialities during prolonged cultivation of myogenic cells Proc Natl Acad Sci USA 1968 61: 477–483.

    Article  CAS  Google Scholar 

  12. Wong DT, Threlkeld PG, Best KL, Bymaster FP . A new inhibitor of norpinepnrine uptake devoid of affinity for receptors in rat brain J Pharm Exp Ther 1982 222: 61–65.

    CAS  Google Scholar 

  13. Wong DT, Bymaster FP, Reid LR . Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors Biochem Pharmac 1983 32: 1287–1293.

    Article  CAS  Google Scholar 

  14. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel antiobesity drug Int J Obes Relat Metab Disord 1998 22 (Suppl 1): S18–S28.

    CAS  PubMed  Google Scholar 

  15. Kahn CR . Insulin resistance, insulin insensitivity and insulin unresponsiveness: a necessary distinction Metabolism 1978 27: 1893–1902.

    Article  CAS  Google Scholar 

  16. Holman GD, Kasuga M . From receptor to transporter: insulin signalling to glucose transport Diabetologia 1997 40: 991–1003.

    Article  CAS  Google Scholar 

  17. Vlahos CJ, Matter WJ, Hui KY, Brown RF . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl-8-phenyl)-4H-1-benzopyran-4-one (LY294002) J Biol Chem 1994 269: 5241–5248.

    CAS  PubMed  Google Scholar 

  18. Klip A, Paquet M . Glucose transport and glucose transporters in muscle and their metabolic regulation Diabetes Care 1990 13: 228–243.

    Article  CAS  Google Scholar 

  19. Koivisto UM, Martinez-Valdez H, Bilan PJ, Burkett E, Ramlal T, Klip A . Differential regulation of GLUT1 and GLUT4 glucose transport systems by glucose and insulin in L6 muscle cells in culture J Biol Chem 1991 266: 2615–2621.

    CAS  PubMed  Google Scholar 

  20. Walker PS, Ramlal T, Sarabia V, Koivisto UM, Bilan PJ, Pessin JE, Klip A . Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription J Biol Chem 1990 265: 1516–1523.

    CAS  PubMed  Google Scholar 

  21. Klip A, Guma A, Ramlel T, Bilan PJ, Lam L, Leiter LA . Stimulation of hexose transport by metformin in L6 muscle cells in culture Endocrinology 1992 130: 2535–2544.

    Article  CAS  Google Scholar 

  22. Henry RR, Wallace P, Olefsky JM . Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus Diabetes 1986 35: 990–998.

    Article  CAS  Google Scholar 

  23. Wing RR, Shoemaker M, Marcus MDM, McDermott M, Gooding W . Variables associated with weight loss and improvements in glycemic control in type 2 diabetic patients Arch Intern Med 1990 147: 1749–1753.

    Article  Google Scholar 

  24. Baron AD, Brechtel G, Wallace P, Edelman SV . Rates and tissue sites of non-insulin and insulin-mediated uptake in humans Am J Physiol 1988 255: E769–E774.

    CAS  PubMed  Google Scholar 

  25. DeFronzo RA . Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes Diabetes Rev 1997 5: 177–269.

    Google Scholar 

  26. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ . Comparison of the effect of sibutramine and other monoamine reuptake inhibitors on food intake in the rat Brit J Pharmac 1997 121: 1758–1762.

    Article  CAS  Google Scholar 

  27. Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR . A comparison of the effects on central 5HT function of sibutramine hydrochloride and other weight-modifying agents Br J Pharmac 1998 25: 301–308.

    Article  Google Scholar 

  28. Bickerdike MJ, Vickers SP, Dourish CT . 5-HT2c receptor modulation and the treatment of obesity Diabetes Obes Metab 1999 1: 207–214.

    Article  CAS  Google Scholar 

  29. Pestell RG, Crock PA, Ward GM, Alford FP, Best JD . Fenfluramine increases insulin action in patients with NIDDM Diabetes Care 1989 12: 252–258.

    Article  CAS  Google Scholar 

  30. Scheen AJ, Paolisso G, Salvatore T, Lefebvre PJ . Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine Diabetes Care 1991 14: 325–332.

    Article  CAS  Google Scholar 

  31. Kirby MJ, Turner P . Fenfluramine and nor-fenfluramine on glucose uptake into skeletal muscle Postgrad Med J 1975 5 (Suppl 1): 73–76.

    Google Scholar 

  32. Sasson S, Kunievsky B, Nathan C, Cerasi E . On the role of 5-hydroxytrytamine in the peripheral action of fenfluramine: studies with the isolated rat soleus muscle Biochem Pharmac 1990 39: 965–968.

    Article  CAS  Google Scholar 

  33. Rowley HL, Bulter SA, Prow MR, Aspley S, Kilpatrick IC, Heal DJ . A comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely-moving rats Synapse 2000 38: 167–176.

    Article  CAS  Google Scholar 

  34. Kosmiski L, Eckel RH . Anorectic agents in non-insulin dependent diabetes mellitus Cur Opin Endocrinol Diabetes 1997 4: 36–39.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Life and Health Sciences, Aston University, Birmingham, UK

    CJ Bailey, SL Turner, SH Bates & RB Jones

Authors
  1. CJ Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. SL Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. SH Bates
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. RB Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bailey, C., Turner, S., Bates, S. et al. Sibutramine metabolites increase glucose transport by cultured rat muscle cells. Int J Obes 25, 478–485 (2001). https://doi.org/10.1038/sj.ijo.0801575

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801575

Keywords

This article is cited by

Search

Advanced search

Quick links